Landiolol: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Landiolol. Educational only — not medical advice.
Labeled uses
RAPIBLYK is indicated for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter, and pediatric patients with supraventricular tachycardia.
Source: FDA labeling via NIH DailyMed (set 411b0949…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.